TG Therapeutics | TGTX - 税前利润



金融业
股票价格
USD
资产
USD 1.06B
现金及等价物
USD 199.51M
销售成本
USD 38.14M
流动资产
USD 630.76M
流动负债
USD 153.76M
债务
USD 245.34M
EBIT
USD 50.49M
EBITDA
USD 32.69M
员工
338
EPS每股收益
USD 0.14
股本和储备
USD 648.02M
销售毛利
USD 154.43M
债务利息支出
USD 6.53M
贷款资金
USD 245.65M
市值
USD 5.19B
净收入
USD 23.04M
营业费用
USD 142.08M
营业利润
USD 50.49M
普通股股本
USD 155.21M
PE价格收益
10.76
税前利润
USD 45.09M
销售收入
USD 192.57M
销售和管理费用
USD 50.73M
股票
USD 125.59M
贸易债权人
USD 61.64M
应收帐款人
USD 265.38M


税前利润 更改 日
AbbVie USD 5.57B 2.9B 2026-03
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 1.51B 2.41B 2025-12
Ardelyx USD -400K 467K 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 377.7M 433.7M 2026-03
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Curis USD 19.36M 33.34M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 7.82B 2.86B 2026-03
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Novartis USD 4.64B 445M 2025-12
Novavax USD 17.9M 220.94M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
TG Therapeutics USD 45.09M 19.18M 2025-12
Verastem USD -32.92M 944K 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09